Results come after positive results from a trial among people with idiopathic pulmomary disease.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The healthcare provisions include Medicaid work requirements and a broadening of the exemption to Medicare drug price negotiation ...

In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...

Climate change and air pollution are growing threats to public health, and new research suggests they may also worsen atopic ...

While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a ...

In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.

Care gaps in women’s health are closing, thanks to increased cultural awareness of gendered healthcare disparities, according ...

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...